NASDAQ:RGC
Regencell Bioscience Holdings Limited
- Stock
Last Close
5.93
25/09 14:11
Market Cap
44.89M
Beta: -
Volume Today
11.69K
Avg: 926
PE Ratio
−17.51
PFCF: −20.60
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Jan '15 | Dec '15 | Dec '16 | Dec '17 | Jun '19 | Jun '20 | Jun '21 | Jun '22 | Jun '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
revenue | 3.04B - | 2.99B 1.58% | 3.13B 4.59% | 3.20B 2.23% | 3.16B 1.07% | ||||||
cost of revenue | 111M - | 111M 0% | 1.21B 987.84% | 1.23B 1.60% | 123M 89.97% | 9.52K - | 26.46K 178.02% | 604.40K 2,184.54% | 769.69K 27.35% | ||
gross profit | 2.93B - | 2.88B 1.64% | 1.92B 33.32% | 1.97B 2.63% | 3.04B 54.29% | -9.52K - | -26.46K 178.02% | -604.40K 2,184.54% | -769.69K 27.35% | ||
selling and marketing expenses | 3.64K - | 114.21K 3,039.28% | 1.58K 98.62% | 25.27K 1,503.74% | 262.66K 939.22% | ||||||
general and administrative expenses | 73.70M - | 74.40M 0.95% | 500.30M 572.45% | 512.20M 2.38% | 86.60M 83.09% | 159.13K 99.82% | 311.93K 96.03% | 941.46K 201.81% | 5.08M 439.62% | 4.43M 12.81% | |
selling general and administrative expenses | 73.70M - | 74.40M 0.95% | 500.30M 572.45% | 512.20M 2.38% | 86.60M 83.09% | 162.77K 99.81% | 426.14K 161.81% | 943.04K 121.30% | 5.11M 441.40% | 4.69M 8.10% | |
research and development expenses | 228.22K - | 386.23K 69.23% | 438.32K 13.49% | 2.51M 473.13% | 1.58M 37.04% | ||||||
other expenses | 1.09B - | 1.12B 3.17% | 1.08B 3.48% | 1.11B 3.09% | 1.22B 9.84% | 34.62K - | 23.21K 32.94% | 211.34K 810.37% | |||
cost and expenses | 2.70B - | 2.68B 0.54% | 2.79B 3.90% | 2.85B 2.32% | 2.89B 1.35% | 390.99K 99.99% | 812.37K 107.77% | 1.38M 70.04% | 7.62M 451.47% | 6.27M 17.64% | |
operating expenses | 1.16B - | 1.19B 3.03% | 1.58B 32.41% | 1.63B 2.87% | 1.31B 19.43% | 390.99K 99.97% | 812.37K 107.77% | 1.38M 70.04% | 7.62M 451.47% | 6.27M 17.64% | |
interest expense | -23.21K - | ||||||||||
ebitda | 469.20M - | 391M 16.67% | 470.30M 20.28% | 512.30M 8.93% | 468.70M 8.51% | -390.99K 100.08% | -802.86K 105.34% | -1.35M 68.76% | -7.01M 417.63% | -5.50M 21.52% | |
operating income | 339.80M - | 306.40M 9.83% | 339M 10.64% | 344.20M 1.53% | 271.70M 21.06% | -390.99K 100.14% | -812.37K 107.77% | -1.38M 70.04% | -7.62M 451.47% | -6.27M 17.64% | |
depreciation and amortization | 204.50M - | 212M 3.67% | 216.80M 2.26% | 230.70M 6.41% | 254.80M 10.45% | 390.99 100.00% | 9.52K 2,333.82% | 26.46K 178.02% | 604.40K 2,184.54% | 769.69K 27.35% | |
total other income expenses net | -75.20M - | -127.80M 69.95% | -85.70M 32.94% | -62.50M 27.07% | -57.80M 7.52% | -1.00 - | 34.62K 3,461,798.40% | 23.21K 32.94% | 211.34K 810.37% | ||
income before tax | 264.60M - | 178.60M 32.50% | 253.30M 41.83% | 281.70M 11.21% | 213.90M 24.07% | -390.99K 100.18% | -812.37K 107.77% | -1.35M 65.78% | -7.59M 463.92% | -6.06M 20.18% | |
income tax expense | 107M - | 73.40M 31.40% | 100.10M 36.38% | 111.20M 11.09% | 101.60M 8.63% | -390.99 100.00% | -1.00 99.74% | -171.83K - | -191.20K 11.27% | ||
net income | 157.70M - | 105.60M 33.04% | 153.40M 45.27% | 170.40M 11.08% | 112.30M 34.10% | -390.99K 100.35% | -812.37K 107.77% | -1.35M 65.78% | -7.42M 451.16% | -5.87M 20.90% | |
weighted average shs out | 154.83M - | 155.29M 0.30% | 156.45M 0.75% | 156.79M 0.21% | 156.34M 0.29% | 12.64M 91.91% | 12.64M 0% | 12.64M 0% | 13.01M 2.93% | 13.01M 0% | |
weighted average shs out dil | 155.72M - | 156.31M 0.38% | 156.50M 0.12% | 156.80M 0.19% | 156.99M 0.12% | 12.64M 91.95% | 12.64M 0% | 12.64M 0% | 13.01M 2.93% | 13.01M 0% | |
eps | 1.02 - | 0.68 33.33% | 0.98 44.12% | 1.09 11.22% | 0.72 33.94% | -0.03 104.29% | -0.06 108.09% | -0.11 71.07% | -0.57 418.18% | -0.45 21.05% | |
epsdiluted | 1.01 - | 0.68 32.67% | 0.98 44.12% | 1.09 11.22% | 0.72 33.94% | -0.03 104.29% | -0.06 108.09% | -0.11 71.07% | -0.57 418.18% | -0.45 21.05% |
All numbers in USD (except ratios and percentages)